UK markets closed

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9016-0.0014 (-0.16%)
At close: 04:00PM EDT
0.9189 +0.02 (+1.92%)
After hours: 07:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 65.63M
Enterprise value -116.81M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.34
Price/book (mrq)0.35
Enterprise value/revenue -16.69
Enterprise value/EBITDA 1.18

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 3-71.25%
S&P500 52-week change 327.86%
52-week high 33.2800
52-week low 30.6700
50-day moving average 30.9116
200-day moving average 31.2730

Share statistics

Avg vol (3-month) 3697.88k
Avg vol (10-day) 31.02M
Shares outstanding 572.8M
Implied shares outstanding 672.8M
Float 852.5M
% held by insiders 114.81%
% held by institutions 167.98%
Shares short (15 Mar 2024) 43.38M
Short ratio (15 Mar 2024) 43.91
Short % of float (15 Mar 2024) 44.80%
Short % of shares outstanding (15 Mar 2024) 44.64%
Shares short (prior month 15 Feb 2024) 43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,503.39%

Management effectiveness

Return on assets (ttm)-25.26%
Return on equity (ttm)-44.54%

Income statement

Revenue (ttm)7M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -104.17M
Net income avi to common (ttm)-101.87M
Diluted EPS (ttm)-1.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)201.37M
Total cash per share (mrq)2.77
Total debt (mrq)18.93M
Total debt/equity (mrq)10.09%
Current ratio (mrq)11.66
Book value per share (mrq)2.58

Cash flow statement

Operating cash flow (ttm)-81.64M
Levered free cash flow (ttm)-39.23M